IP Library Patent Application 13081531
Patent Application
App. No. 13/081,531

Biodegradable Polymer Encapsulated Microsphere Particulate Film and Method of Making Thereof

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/081,531
Abstract

Films containing microsphere particles and processes for forming thereof are disclosed. The microsphere particles encapsulate one or more bioactive agents and may be deposited on a surface of medical devices or be used to form a medical device.

Claims (48)

1 . A medical device comprising:

a film including a plurality of poly(lactic-co-glycolic acid) microsphere particles disposed therein, wherein the plurality of poly(lactic-co-glycolic acid) microsphere particles encapsulate at least one bioactive agent; and

a film former.

2 . The medical device according to claim 1 , wherein the poly(lactic-co-glycolic acid) is of formula:

wherein x is from about 50 to about 70, y is from about 30 to about 50, and n is from about 20 to about 1000.

3 . The medical device according to claim 2 , wherein x is from about 50 to about 60, y is from about 32 to about 40, and n is from about 300 to about 500.

4 . The medical device according to claim 1 , wherein the film is formed from a single emulsion.

5 . The medical device according to claim 1 , wherein the film is formed from a double emulsion.

6 . The medical device according to claim 1 , wherein the at least one bioactive agent includes a water-soluble drug.

7 . The medical device according to claim 6 , wherein the water-soluble drug is bupivacaine hydrochloride.

8 . The medical device according to claim 6 , wherein the film former is polyvinyl alcohol hydrolyzed from about 80% to about 99%.

9 . A film comprising:

a dried emulsion including:

a first component including a water-soluble drug and a first polar solvent;

a second component including an aliphatic-polyester and a non-polar solvent; and

a third component including a water-soluble polymer and a second polar solvent.

10 . The film according to claim 9 , wherein the aliphatic-polyester is present in an amount from about 1% by weight to about 5% by weight of the non-polar solvent.

11 . The film according to claim 9 , wherein the water-soluble drug is present in an amount from about 1% by weight to about 5% by weight of the first polar solvent.

12 . The film according to claim 9 , wherein the water-soluble polymer is present in an amount of about 1% by weight of the second polar solvent.

13 . The film according to claim 9 , wherein the non-polar solvent is methylene chloride.

14 . The film according to claim 9 , wherein the first polar solvent is methanol.

15 . The film according to claim 9 , wherein the second polar solvent is water.

16 . A process comprising:

forming a first, non-polar composition containing at least one biodegradable polymer, at least one bioactive agent and at least one non-polar solvent;

forming a second, polar composition containing at least one emulsifier and at least one polar solvent;

forming an emulsion by contacting the first, non-polar composition and the second, polar composition;

homogenizing the emulsion to form microsphere particles comprising the at least one biodegradable polymer encapsulating the at least one bioactive agent; and

drying the homogenized emulsion to form a film including the microsphere particles disposed therein.

17 . The process according to claim 16 , further comprising:

removing the at least one non-polar solvent from the emulsion.

18 . The process according to claim 16 , wherein the at least one biodegradable polymer is of formula:

wherein x is from about 50 to about 70, y is from about 30 to about 50, and n is from about 20 to about 1000.

19 . The process according to claim 18 , wherein x is from about 50 to about 60, y is from about 32 to about 40, and n is from about 300 to about 500.

20 . The process according to claim 16 , wherein the at least one emulsifier is polyvinyl alcohol hydrolyzed from about 80% to about 99%.

21 . The process according to claim 16 , further comprising:

depositing the homogenized emulsion on at least a portion of a medical device prior to drying the homogenized emulsion.

22 . A process comprising:

forming a mixture by contacting a first, non-polar composition comprising at least one biodegradable polymer and at least one non-polar solvent with a second, polar composition comprising least one bioactive agent in at least one polar solvent;

forming an emulsion by contacting the mixture with at least one emulsifier;

homogenizing the emulsion to form microsphere particles comprising the at least one biodegradable polymer encapsulating the at least one bioactive agent; and

drying the homogenized emulsion to form a film including the microsphere particles disposed therein.

23 . The process according to claim 22 , further comprising:

removing the at least one non-polar solvent from the emulsion.

24 . The process according to claim 22 , wherein the at least one biodegradable polymer is of formula:

wherein x is from about 50 to about 70, y is from about 30 to about 50, and n is from about 20 to about 1000.

25 . The process according to claim 24 , wherein the at least one emulsifier is polyvinyl alcohol hydrolyzed from about 80% to about 99%.

26 . The process according to claim 22 , further comprising:

depositing the homogenized emulsion on at least a portion of a medical device prior to drying the homogenized emulsion.

Assignments (3)
CHANGE OF NAME Recorded Oct 2, 2012
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029065/0448 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2011
From: STOPEK, JOSHUA
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 026174/0236 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2011
From: GRIFFIN, JEREMY; ELACHCHABI, AMIN
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 026086/0870 →